Javascript must be enabled to continue!
Mechanism of action of catestatin as an autocrine modulator regulating catecholamine secretion from chromaffin cells at the of splanchnicoadrenomedullary synapse
View through CrossRef
ObjectiveThe chromogranin A (CgA)‐derived peptide catestatin (CST: human CgA352–372) is thought to act as an autocrine modulator of catecholamine secretion from the adrenal medulla in vivo. Here, we examined how CST affects nicotine‐ and PACAP‐induced secretion from, and protein resynthesis within, dense core (DC) vesicle (DCV) quanta containing catecholamines and chromogranin/secretogranin proteins in PC12 cells.Methods and ResultsDepletion of norepinephrine (NE) from PC12 cells treated acutely (0.5 hours) with either nicotine (60 μM)‐ or PACAP (0.1 μM) was reversed by CST (2 μM), as was 3H‐NE release elicited by both secretagogues. DCV and DC area and diameter, evaluated by Transmission Electron Microscopy, were both decreased after treatment with either nicotine or PACAP, and this morphological effect was likewise reversed by CST. Nicotine or CST alone increased expression of CgA protein (but not CgB), and, in combination, elicited an additional increase in CgA protein, implying that nicotine and CST utilize separate signaling pathways to activate expression of CgA. In contrast, PACAP increased expression of CgB protein (but not CgA), indicating differential regulation of CgA and CgB proteins by cholinergic and peptidergic stimulation. Although CST augmented expression of tyrosine hydroxylase (TH) protein, it did not induce synthesis of catecholamines, presumably due to its inability to cause post‐translation activation of TH via serine phosphorylation. Increased area and diameter of DCVs, and their DCs after CST, CST+nicotine and CST+PACAP are consistent with increased quantal size. Decreased quantal size is possibly mediated by increased synthesis of granulogenic proteins: CgA after CST treatment; CgA after CST+nicotine treatment; and CgB after CST+PACAP treatment.ConclusionBased on our results obtained in PC12 cells, we suggest that the CgA‐derived peptide CST acts as a paracrine factor during ACh or PACAP stimulation of secretion from chromaffin cells of the adrenal medulla, modulating both the extent of secretory stimulation by splanchnic nerve firing, and the repletion of secretory granule content after bouts of secretory activity.Support or Funding InformationSupported by grants from the VA (I01BX000323 to S.K.M.; I01BX002709 to N.J.G.W), and the NIH (MH002386 to L.E.E.).This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
Title: Mechanism of action of catestatin as an autocrine modulator regulating catecholamine secretion from chromaffin cells at the of splanchnicoadrenomedullary synapse
Description:
ObjectiveThe chromogranin A (CgA)‐derived peptide catestatin (CST: human CgA352–372) is thought to act as an autocrine modulator of catecholamine secretion from the adrenal medulla in vivo.
Here, we examined how CST affects nicotine‐ and PACAP‐induced secretion from, and protein resynthesis within, dense core (DC) vesicle (DCV) quanta containing catecholamines and chromogranin/secretogranin proteins in PC12 cells.
Methods and ResultsDepletion of norepinephrine (NE) from PC12 cells treated acutely (0.
5 hours) with either nicotine (60 μM)‐ or PACAP (0.
1 μM) was reversed by CST (2 μM), as was 3H‐NE release elicited by both secretagogues.
DCV and DC area and diameter, evaluated by Transmission Electron Microscopy, were both decreased after treatment with either nicotine or PACAP, and this morphological effect was likewise reversed by CST.
Nicotine or CST alone increased expression of CgA protein (but not CgB), and, in combination, elicited an additional increase in CgA protein, implying that nicotine and CST utilize separate signaling pathways to activate expression of CgA.
In contrast, PACAP increased expression of CgB protein (but not CgA), indicating differential regulation of CgA and CgB proteins by cholinergic and peptidergic stimulation.
Although CST augmented expression of tyrosine hydroxylase (TH) protein, it did not induce synthesis of catecholamines, presumably due to its inability to cause post‐translation activation of TH via serine phosphorylation.
Increased area and diameter of DCVs, and their DCs after CST, CST+nicotine and CST+PACAP are consistent with increased quantal size.
Decreased quantal size is possibly mediated by increased synthesis of granulogenic proteins: CgA after CST treatment; CgA after CST+nicotine treatment; and CgB after CST+PACAP treatment.
ConclusionBased on our results obtained in PC12 cells, we suggest that the CgA‐derived peptide CST acts as a paracrine factor during ACh or PACAP stimulation of secretion from chromaffin cells of the adrenal medulla, modulating both the extent of secretory stimulation by splanchnic nerve firing, and the repletion of secretory granule content after bouts of secretory activity.
Support or Funding InformationSupported by grants from the VA (I01BX000323 to S.
K.
M.
; I01BX002709 to N.
J.
G.
W), and the NIH (MH002386 to L.
E.
E.
).
This abstract is from the Experimental Biology 2019 Meeting.
There is no full text article associated with this abstract published in The FASEB Journal.
Related Results
Loss and Ca2+‐Dependent Retention of Scinderin in Digitonin‐Permeabilized Chromaffin Cells: Correlation with Ca2+‐Evoked Catecholamine Release
Loss and Ca2+‐Dependent Retention of Scinderin in Digitonin‐Permeabilized Chromaffin Cells: Correlation with Ca2+‐Evoked Catecholamine Release
Abstract: Exposure of chromaffin cells to digitonin causes the loss of many cytosolic proteins. Here we report that scinderin (a Ca2+‐dependent actin‐filament‐severing protein), b...
Cardiovascular-a new novel source of catestatin and its precursor chromogranin A
Cardiovascular-a new novel source of catestatin and its precursor chromogranin A
Objective
To investigate the expression and distribution of catestatin and its precursor phromogranin A in tissue and cardiovascular cell levels.
...
Synapse formation in the mouse olfactory bulb Quantitative studies
Synapse formation in the mouse olfactory bulb Quantitative studies
AbstractA quantitative study of synapse formation in the mouse olfactory bulb has been carried out using serial sections. Volumetric synaptic density as well as absolute number of ...
Catestatin: Antimicrobial Functions and Potential Therapeutics
Catestatin: Antimicrobial Functions and Potential Therapeutics
The Chromogranin A (CgA)-derived peptide Catestatin (CST: hCgA352-372) is highly conserved (>90% in 90% species) in mammalian species. The highest-evolved primates show 58.8...
Regulation of IgA differentiation in CH12LX B cells by lymphokines. IL-4 induces membrane IgM-positive CH12LX cells to express membrane IgA and IL-5 induces membrane IgA-positive CH12LX cells to secrete IgA.
Regulation of IgA differentiation in CH12LX B cells by lymphokines. IL-4 induces membrane IgM-positive CH12LX cells to express membrane IgA and IL-5 induces membrane IgA-positive CH12LX cells to secrete IgA.
Abstract
In these studies we utilized the Ag (SRBC)-reactive B cell line CH12LX to study isotype switching. CH12LX cells are a stable population of B cells mainly be...
INTEGRATING GENOMIC AND FUNCTIONAL TESTING TO IMPROVE CFTR MODULATOR RESPONSE PREDICTION IN CHILDREN WITH CYSTIC FIBROSIS
INTEGRATING GENOMIC AND FUNCTIONAL TESTING TO IMPROVE CFTR MODULATOR RESPONSE PREDICTION IN CHILDREN WITH CYSTIC FIBROSIS
ABSTRACT
Background
CFTR modulators have transformed cystic fibrosis (CF) treatment, but individual responses vary even among patients wi...
Interferon‐βMediates Opposing Effects on Interferon‐γ‐dependent Interleukin‐12 p70 Secretion by Human Monocyte‐Derived Dendritic Cells
Interferon‐βMediates Opposing Effects on Interferon‐γ‐dependent Interleukin‐12 p70 Secretion by Human Monocyte‐Derived Dendritic Cells
AbstractInterferon‐β(IFN‐β) exposure during tumour necrosis factor‐α(TNF‐α)‐induced human monocyte‐derived dendritic cell (DC) maturation augments the capacity of DC to promote the...
Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma
Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma
Tumor cells express vascular endothelial growth factor (VEGF) that can activate VEGF receptors (VEGFRs) on or within tumor cells to promote growth in an angiogenesis-independent fa...

